News

According to Jennerex, the presented data demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV. Choi (necrotic) responses

Intellipharmaceutics said that the successful manufacture of clinical batches is required to make the drug eligible for Phase I studies and to establish a clinical program in cooperation

As per the terms of the agreement OEP will be responsible for clinical study expenses related to an ASC-J9 Phase IIb multi center trial in acne vulgaris. Scheduled

Swanson said that the reformulation of FemFlora is to address a woman’s complex probiotic needs. The new Swanson Ultra FemFlora contains multiple lactobacilli species to support the flora

Eli Lilly said that the Phase II study evaluated the use of Tasisulam as a second-line treatment in patients with unresectable or metastatic melanoma. The trial’s primary objective

According to the Genentech, the PRIMA study enrolled patients with previously untreated advanced follicular lymphoma. After two-years of follow-up, 82% of patients who received Rituxan maintenance were in

The US patent 7,695,956, entitled ‘Device for Cell Separation and Analysis and Method of Using,’ protects Biocept’s microflow device to isolate cells from a bodily fluid using a

Abbott said that the acquisition further accelerates its market growth following the recent acquisition of Solvay Pharmaceuticals and collaboration with Zydus Cadila as well as the creation of

Sorrento said that the grant was awarded to support the its program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus (S aureus or